SAEVA Proceedings 2015 | Page 60

South African Equine Veterinary Association Congress 2015  Protea Hotel  Stellenbosch Also unlike Cushing‟s disease in humans and dogs, adrenocortical hyperplasia accompanying equine Cushing‟s disease is relatively uncommon, occurring in ~20% of affected horses. These differences in location and pathophysiology between human, canine, and equine pituitary adenomas have lead several authors to suggest that the disease in horses should not be called equine Cushing‟s disease; rather, pituitary pars intermedia dysfunction (PPID) has been advanced as a more appropriate descriptor. Clinical signs: The classic clinical sign of PPID in horses is hypertrichosis, a long and curly hair coat that fails to shed. In some affected horses, coat colour changes have also been observed. The pathogenesis of hypertrichosis, characterized by arrest of hair follicles in anagen, remains unclear. Abnormal sweating, both hyperhidrosis and anhidrosis, is also observed in up to two-thirds of horses with PIPD. Weight loss and lethargy, or poor performance, can also be observed in horses with PPID. In addition to true weight loss, protein catabolism due to increased cortisol activity leads to loss of muscle mass. This is most notable in advanced cases as a loss of epaxial and rump musculature. Despite weight loss, appetite in affected horses is normal or even increased (polyphagia). However, dental abnormalities, leading to painful mastication and quidding, may compromise feed intake and contribute to weight loss in some horses. Combined with, or often preceding, loss of muscle mass in some horses is insulin resistance and deposition of fat along the crest of the neck, over the tail head, and in the sheath of male horses. Another area where abnormal fat deposition may occur is above and behind the eyes (supraorbital area). Horses with PPID have also been described as overly docile and more tolerant of pain than normal horses. The latter signs have been attributed to increased plasma and cerebrospinal fluid concentrations of endorphin that are 60- and more than 100-fold greater, respectively, in horses with PPID than in normal horses. Chronic, insidious-onset laminitis is perhaps the major clinical complication of PPID with more than 50% of horses affected in most reports. Although the condition is more amenable to management in ponies due to their lower body weight, chronic or recurrent pain with exacerbation of laminitis or associated foot abscesses is often the reason for euthanasia. Polydipsia and polyuria (PU/PD) develops in about one-third of horses with PPID. Equids with PPID tend to have delayed wound healing and are frequently affected with secondary infections. Commonly recognized infections include skin infections (e.g., refractory “scratches” and fistulous tracts), recurrent subsolar abscesses, conjunctivitis, sinusitis, gingivitis, alveolar periostitis, and bronchopneumonia. Other signs that have been reported in horses with PPID include persistent mammary secretions and infertility. Central nervous system (CNS) dysfunction, including ataxia, blindness, and seizure-like activity, are occasionally observed in equids with PPID. A major complication of hypercortisolism in affected human patients is osteoporosis. Although occurrence of this complication has not been investigated in horses, it is interesting to note that euthanasia of horses with PPID has been reported due to development of pelvic, pedal bone, mandibular, and multiple rib fractures. Clinicopathologic findings: Abnormal laboratory data in horses with PPID may include mild anaemia, an absolute or relative neutrophilia, and an absolute or relative lymphopenia. As well as being increased in number, neutrophils in affected animals may appear hypersegmented. This finding reflects maturity of neutrophils and can be attributed to a longer half-life of circulating neutrophils because cortisol excess limits diapedesis from the vasculature. The most common abnormality detected on serum biochemical evaluation is mild to moderate hyperglycaemia, reported in 25-75% of cases, depending on the upper end of the reference range used. Additional 60